ACIP Recommendations for Non-Respiratory Immunizations Remain Largely Unchanged | NCPA 2024
Drug Topics
OCTOBER 27, 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
OCTOBER 27, 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
Drug Topics
APRIL 17, 2023
At the 44th annual National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule that details new changes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 7, 2025
Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.
Drug Topics
APRIL 9, 2024
Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.
Drug Topics
FEBRUARY 7, 2025
RBI-4000 is a self-replicating RNA (srRNA) vaccine developed to stimulate virus-neutralizing immune responses to rabies for prophylactic use.
Drug Topics
JANUARY 1, 2025
Check out this list of our top 5 most read immunization stories from the year 2024.
Drug Topics
MAY 21, 2024
Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.
Drug Topics
MARCH 11, 2025
IQVIA released a report detailing pharmacists authority to administer vaccines in the US as well as adults overall vaccination rates by state.
Drug Topics
JULY 16, 2024
COVID-19 patients had reduced absolute granulocyte, monocyte, and lymphocyte counts at 10 months post-infection compared to noninfected individuals.
Drug Topics
OCTOBER 10, 2023
Patients with rheumatoid arthritis had a higher risk of shingles when treated once a day with 4 mg of baricitinib, 100 mg of peficitinib, or 30 mg of upadacitinib.
Drug Topics
DECEMBER 16, 2022
Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures.
Drug Topics
SEPTEMBER 25, 2023
A new study from Yale School of Medicine and Icahn School of Medicine at Mount Sinai found that patients with long COVID had increased antibodies that help fight different viruses and lower levels of cortisol.
Drug Topics
JUNE 27, 2023
Immune-checkpoint inhibitors were comparably safe and effective in patients with chronic hepatitis B or occult hepatitis B infection.
Drug Topics
DECEMBER 7, 2022
The shingles vaccine appears to confer long-term immunity, according to research.
Drug Topics
APRIL 1, 2025
Community pharmacies have a clear role in public health, as they manage ongoing services and take on a more significant role as immunizers.
Drug Topics
MARCH 27, 2024
mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5 5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine.
Drug Topics
OCTOBER 31, 2023
The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.
Drug Topics
JANUARY 3, 2025
Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.
Drug Topics
APRIL 30, 2024
Recent research on COVID-19 vaccination shows that vaccines help fight variants, led to lower cases among children in California, and that boosters provide longer lasting protection.
Drug Topics
DECEMBER 24, 2023
Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.
Drug Topics
APRIL 24, 2024
In response to historically low flu vaccine coverage rates, Kristen Thorson, PharmD, urges pharmacists to think back to their pandemic immunization efforts and “know the power of their recommendation,” to boost public protection from influenza.
Drug Topics
MARCH 26, 2024
Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.
Drug Topics
AUGUST 30, 2022
This National Immunization Awareness Month, prepare your pharmacy to offer important vaccines.
Drug Topics
NOVEMBER 19, 2024
James, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.
PharmaVoice
SEPTEMBER 11, 2023
After dropping its neuroscience program earlier this year, the clinical-stage oncology company is doubling down on a candidate targeting the MAPK pathway.
Drug Topics
MARCH 27, 2023
The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.
Drug Topics
OCTOBER 7, 2023
During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.
Drug Topics
MAY 30, 2023
Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
Drug Topics
OCTOBER 2, 2023
Vaccines were tested against various strains of the SARS-CoV-2 virus.
PharmaVoice
JULY 14, 2022
The company’s chief medical officer discusses its lead candidate and how it fits into wider oncology trends.
STAT
JULY 10, 2024
But new research asks the question: What if immune cells could be turned back into good guys, and actually help save tissue damaged by autoimmune disease? Lupus is complicated because it wields the body’s own defenses against itself, generating a continuous immune misfire. Read the rest…
Drug Topics
JUNE 9, 2023
Cytokine signaling pathways in sera from underrepresented minority patients were found to be enriched.
Drug Topics
OCTOBER 3, 2024
Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
Drug Topics
MARCH 5, 2025
Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients willingness to return for future immunization.
Pharmacy Times
JUNE 4, 2024
The immunizing technicians stated they had greater job satisfaction and had a greater sense of being valuable pharmacy members
STAT
APRIL 10, 2024
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest acquisition in Vertex’s history.
Pharmacy Times
JULY 26, 2024
Study finds traces of “epigenetic scars” on the immune cells of patients who recovered from chronic hepatitis C infection.
Drug Topics
NOVEMBER 18, 2024
Drug Topics sat down with Adam J. James, PharmD, to discuss his journey from chain pharmacist to innovation leader at Rite Aid."
STAT
OCTOBER 13, 2023
As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.
Pharmacy Times
APRIL 4, 2025
The new designations span both warm autoimmune hemolytic anemia and IgG4-related disease, 2 rare, immune-mediated conditions that burden patients due to a lack of available treatment options.
STAT
FEBRUARY 14, 2024
The study , published Wednesday in Nature, underscores the importance of never lighting up that first cigarette, based on its conclusion that smoking has much longer harmful effects on immune responses than previously understood. Read the rest…
Pharmacy Times
SEPTEMBER 21, 2023
Two separate study findings reported that a subset of dormant CD4+ cells could spontaneously produce HIV RNA and proteins, impacting a patient’s HIV-specific immune responses.
Pharmacy Times
JANUARY 2, 2024
The new understanding of immune cells could not only contribute to the development of lung disease treatments, but treatments for other organ systems as well.
Drug Topics
SEPTEMBER 5, 2023
The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content